AbCellera's Surges on Antibody Collaboration with Biogen

Monday, 11 March 2024, 16:23

AbCellera Biologics experiences a 3% surge following the announcement of a collaboration with Biogen to develop neurological antibodies. This partnership holds significant promise for advancing treatments in the field of neurology and underscores AbCellera's commitment to innovative therapeutic solutions.
https://store.livarava.com/676953d4-e013-11ee-9662-5254a2021b2b.jpe
AbCellera's Surges on Antibody Collaboration with Biogen

AbCellera Collaborates with Biogen

AbCellera Biologics experiences a 3% surge following the announcement of a collaboration with Biogen to develop neurological antibodies.

Potential Impact on Neurological Treatments

This partnership holds significant promise for advancing treatments in neurology with innovative antibody solutions from AbCellera and Biogen.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe